For in vitro experiments, human cell lines that were thought to be major cell types of AAA indicated that the levels of SREBF1 and total miR-33 copy numbers increased and the levels of ABCA1 decreased after treatment with anti-miR-33a. Here, SREBF1 is linked to triple-A syndrome.